首页 | 本学科首页   官方微博 | 高级检索  
     

恶性黑色素瘤的生物治疗和生物化疗
引用本文:李玉升,屈凤莲,李峻岭. 恶性黑色素瘤的生物治疗和生物化疗[J]. 中华肿瘤杂志, 2000, 23(5): 430-431
作者姓名:李玉升  屈凤莲  李峻岭
作者单位: 
摘    要:

关 键 词:黑色素瘤/治疗  黑色素瘤/药物疗法  生物疗法  生物化学疗法

Biotherapy and biochemotherapy of patients with malignant melanoma
Y Li,F Qu,J Li. Biotherapy and biochemotherapy of patients with malignant melanoma[J]. Chinese Journal of Oncology, 2000, 23(5): 430-431
Authors:Y Li  F Qu  J Li
Affiliation:Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China.
Abstract:OBJECTIVE: To evaluate the efficacy of postoperative biochemotherapy on survival of patients with malignant melanoma. METHODS: One hundred and five patients with malignant melanoma received postoperative biotherapy/biochemotherapy or radiotherapy/chemotherapy. The median time of follow-up was 3 years (from 1 to 5 years). RESULTS: The median survival time (MST) in the whole series of patients was 27 months (range: 2-72 months). The MST in patients received postoperative biotherapy/biochemotherapy (57 cases) was 32 months with a 3-year survival rate of 36.8%. That in patients received postoperative radiotherapy/chemotherapy (54 cases) was 20 months. CONCLUSION: Biotherapy/biochemotherapy following surgery may significantly improve survival in patients with malignant melanoma.
Keywords:
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号